NCT06138756View on ClinicalTrials.gov

Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN)

CompletedOBSERVATIONAL
Enrollment

293

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

May 18, 2024

Study Completion Date

June 1, 2024

Conditions
Migraine
Interventions
DEVICE

Nerivio

Nerivio is a remote electrical neuromodulation (REN) device for the treatment of migraine

Trial Locations (2)

4250438

Theranica Bio-Electronics Ltd, Netanya

08807

Theranica USA Inc, Bridgewater

Sponsors

Lead Sponsor

Theranica
All Listed Sponsors
lead

Theranica

INDUSTRY

NCT06138756 - Acute Treatment of Migraine in Pre-Adolescents: Real-World Analysis of Remote Electrical Neuromodulation (REN) | Biotech Hunter | Biotech Hunter